Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
Karla A. Lee, Andrew Maltez Thomas, Laura A. Bolte, et al.
Nature Medicine (2022) Vol. 28, Iss. 3, pp. 535-544
Open Access | Times Cited: 278

Showing 1-25 of 278 citing articles:

Hallmarks of aging: An expanding universe
Carlos López-Otı́n, Marı́a A. Blasco, Linda Partridge, et al.
Cell (2023) Vol. 186, Iss. 2, pp. 243-278
Open Access | Times Cited: 2710
Immune checkpoint therapy—current perspectives and future directions
Padmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1652-1669
Closed Access | Times Cited: 441
Targeting the gut and tumor microbiota in cancer
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 318
Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment
Mackenzie Bender, Alex McPherson, Catherine M. Phelps, et al.
Cell (2023) Vol. 186, Iss. 9, pp. 1846-1862.e26
Open Access | Times Cited: 299
Gut microbiota in colorectal cancer development and therapy
Chi Chun Wong, Jun Yu
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 429-452
Closed Access | Times Cited: 278
Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends
Qian Sun, Zhenya Hong, Cong Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 233
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
Bertrand Routy, John Lenehan, Wilson H. Miller, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 2121-2132
Closed Access | Times Cited: 201
Targeting the gut microbiota for cancer therapy
Miriam R. Fernandes, Poonam Aggarwal, Raquel Costa, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 703-722
Closed Access | Times Cited: 149
Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
Rebecca Simpson, Erin R. Shanahan, Marcel Batten, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2344-2352
Closed Access | Times Cited: 141
The coming decade in precision oncology: six riddles
Adam Wahida, Lars Buschhorn, Stefan Fröhling, et al.
Nature reviews. Cancer (2022) Vol. 23, Iss. 1, pp. 43-54
Closed Access | Times Cited: 139
Machine learning and deep learning applications in microbiome research
Ricardo Hernández Medina, Svetlana Kutuzova, K Nielsen, et al.
ISME Communications (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 138
Key determinants of success in fecal microbiota transplantation: From microbiome to clinic
Serena Porcari, Nicolas Benech, Mireia Vallès-Colomer, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 5, pp. 712-733
Open Access | Times Cited: 117
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
Christoph K. Stein‐Thoeringer, Neeraj Saini, Eli Zamir, et al.
Nature Medicine (2023) Vol. 29, Iss. 4, pp. 906-916
Open Access | Times Cited: 114
Microbiome-based interventions to modulate gut ecology and the immune system
Thomas C. A. Hitch, Lindsay J. Hall, Sarah Kate Walsh, et al.
Mucosal Immunology (2022) Vol. 15, Iss. 6, pp. 1095-1113
Open Access | Times Cited: 105
Drug-microbiota interactions: an emerging priority for precision medicine
Qing Zhao, Yao Chen, Weihua Huang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 79
Machine learning for microbiologists
Francesco Asnicar, Andrew Maltez Thomas, Andrea Passerini, et al.
Nature Reviews Microbiology (2023) Vol. 22, Iss. 4, pp. 191-205
Open Access | Times Cited: 79
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 583-603
Closed Access | Times Cited: 69
Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts
Lijun Ning, Yilu Zhou, Han Sun, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 68
The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
Su Yin Lim, Elena Shklovskaya, Jenny Lee, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 59
Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions
Chenyue Zhang, Chenxing Zhang, Haiyong Wang
Cancer Letters (2023) Vol. 562, pp. 216182-216182
Closed Access | Times Cited: 55
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
Ashley M. Holder, Aikaterini Dedeilia, Kailan Sierra-Davidson, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 7, pp. 498-512
Closed Access | Times Cited: 54
Intestinal bacteria and colorectal cancer: etiology and treatment
Michael W. Dougherty, Christian Jobin
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 53
Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors
Rebecca Simpson, Erin R. Shanahan, Richard A. Scolyer, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 10, pp. 697-715
Closed Access | Times Cited: 53
Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy
Tianqun Lang, Runqi Zhu, Xiao Zhu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 48
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Johannes R. Björk, Laura A. Bolte, Andrew Maltez Thomas, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 785-796
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top